There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aura Biosciences Inc (AURA – Research Report), Haemonetics (HAE – Research Report) and GH Research (GHRS – Research Report) with bullish sentiments.
Aura Biosciences Inc (AURA)
In a report released today, Jonathan Wolleben from JMP Securities reiterated a Buy rating on Aura Biosciences Inc, with a price target of $24.00. The company’s shares closed last Thursday at $10.21, close to its 52-week low of $8.13.
According to TipRanks.com, Wolleben is a 4-star analyst with an average return of 8.1% and a 41.6% success rate. Wolleben covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Crinetics Pharmaceuticals, and Madrigal Pharmaceuticals.
Aura Biosciences Inc has an analyst consensus of Strong Buy, with a price target consensus of $30.67.
See the top stocks recommended by analysts >>
Haemonetics (HAE)
JMP Securities analyst David Turkaly reiterated a Buy rating on Haemonetics today and set a price target of $115.00. The company’s shares closed last Thursday at $85.84, close to its 52-week high of $91.39.
According to TipRanks.com, Turkaly is a 3-star analyst with an average return of 1.0% and a 45.3% success rate. Turkaly covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Integra Lifesciences, and OrthoPediatrics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Haemonetics with a $106.67 average price target, representing a 29.6% upside. In a report issued on May 10, Mizuho Securities also maintained a Buy rating on the stock with a $115.00 price target.
GH Research (GHRS)
In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on GH Research, with a price target of $49.00. The company’s shares closed last Thursday at $10.17.
According to TipRanks.com, Butler has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -5.1% and a 40.2% success rate. Butler covers the Healthcare sector, focusing on stocks such as Applied Molecular Transport, ACADIA Pharmaceuticals, and Aquestive Therapeutics.
Currently, the analyst consensus on GH Research is a Strong Buy with an average price target of $37.40.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AURA:
ncG1vNJzZmilkae4psDSZ5muq5mjsrS%2FyKeqopyVp3uku8xopZ6vo2TAtbvCpKpomZ6Wubq%2F06xkraegYrWmrcutn5yZopp6sbXCpKpmmaWnrm6uyKiqnKGVo7Cmv4yipZxlkaq%2FonnHmpymp56awaqv0mafmp1dZn10fpJraG1xYQ%3D%3D